Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

INVO Bioscience, Inc. INVO NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
28/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

INVO Bioscience, Inc. (INVO) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.

INVO Analyst Ratings

Buy
2
Ratings
1 Buy
1 Hold
Based on 2 analysts giving stock ratings to INVO Bioscience, Inc. in the past 3 months
Rating breakdown
Buy
1 50%
Hold
1 50%
50%
Buy
1 analysts
50%
Hold
1 analysts
0%
Sell
0 analysts

People Also View

ENTX
ENTX
Entera Bio Ltd.
$1.13
+0.89%
 CLPS
CLPS
CLPS Incorporation
$0.98
-3.64%
 LIXT
LIXT
Lixte Biotechnology Holdings, Inc.
$2.91
-0.68%
 ENVB
ENVB
Enveric Biosciences, Inc.
$1.95
-1.02%
 NLSP
NLSP
NLS Pharmaceutics AG
$2.91
-12.61%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message